Lowey Dannenberg P.C. has filed a class action lawsuit against DexCom, Inc. (NASDAQ: DXCM) alleging violations of federal securities laws. The lawsuit claims that DexCom made unauthorized material design changes to its G6 and G7 devices, rendering them less reliable and posing health risks, which led to a precipitous decline in DexCom's stock value. Investors who suffered losses exceeding $100,000 are encouraged to contact the firm.

德康醫療

<p>Lowey Dannenberg P.C. 已對 DexCom, Inc. (NASDAQ: DXCM) 提起集體訴訟，指控其違反聯邦證券法。訴訟稱，DexCom 對其 G6 和 G7 設備進行了未經授權的重大設計更改，導致設備可靠性降低並帶來健康風險，從而導致 DexCom 股票價值急劇下跌。遭受超過 $100,000 損失的投資者被鼓勵與該公司聯繫</p>

Lowey Dannenberg 通知德康醫療公司（“德康醫療” 或